Aequus Pharmaceuticals Inc. (TSXV:AQS)

Aequus Pharmaceuticals Revenue

Aequus Pharmaceuticals had revenue of 148.32K CAD in the quarter ending September 30, 2024, with 1,010.26% growth. This brings the company's revenue in the last twelve months to 413.17K, down -29.63% year-over-year. In the year 2023, Aequus Pharmaceuticals had annual revenue of 254.90K, down -81.53%.

• Revenue (ttm): 413.17K
• Revenue Growth: -29.63%
• P/S Ratio: 1.61
• Revenue / Employee: n/a
• Employees: 12
• Market Cap: 663.17K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	254.90K	-1.12M	-81.53%
Dec 31, 2022	1.38M	-1.33M	-49.17%
Dec 31, 2021	2.71M	122.09K	4.71%
Dec 31, 2020	2.59M	960.09K	58.81%
Dec 31, 2019	1.63M	222.28K	15.76%